JPMorgan Chase & Co’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.59K | Sell |
324
-13,217
| -98% | -$106K | ﹤0.01% | 5620 |
|
|
2025
Q1 | $132K | Sell |
13,541
-12,105
| -47% | -$118K | ﹤0.01% | 4612 |
|
|
2024
Q4 | $324K | Buy |
25,646
+23,558
| +1,128% | +$298K | ﹤0.01% | 4345 |
|
|
2024
Q3 | $33.6K | Buy |
2,088
+16
| +0.8% | +$257 | ﹤0.01% | 5092 |
|
|
2024
Q2 | $50.5K | Sell |
2,072
-359
| -15% | -$8.76K | ﹤0.01% | 4899 |
|
|
2024
Q1 | $175K | Sell |
2,431
-848
| -26% | -$60.9K | ﹤0.01% | 4502 |
|
|
2023
Q4 | $652K | Sell |
3,279
-21
| -0.6% | -$4.18K | ﹤0.01% | 3769 |
|
|
2023
Q3 | $439K | Buy |
3,300
+248
| +8% | +$33K | ﹤0.01% | 3798 |
|
|
2023
Q2 | $457K | Sell |
3,052
-22
| -0.7% | -$3.29K | ﹤0.01% | 3810 |
|
|
2023
Q1 | $451K | Buy |
3,074
+1,013
| +49% | +$149K | ﹤0.01% | 3892 |
|
|
2022
Q4 | $326K | Buy |
2,061
+9
| +0.4% | +$1.42K | ﹤0.01% | 3973 |
|
|
2022
Q3 | $395K | Buy |
2,052
+118
| +6% | +$22.7K | ﹤0.01% | 3867 |
|
|
2022
Q2 | $283K | Buy |
1,934
+237
| +14% | +$34.7K | ﹤0.01% | 4170 |
|
|
2022
Q1 | $299K | Buy |
1,697
+325
| +24% | +$57.3K | ﹤0.01% | 4242 |
|
|
2021
Q4 | $403K | Sell |
1,372
-888
| -39% | -$261K | ﹤0.01% | 4184 |
|
|
2021
Q3 | $561K | Buy |
2,260
+1,240
| +122% | +$308K | ﹤0.01% | 3903 |
|
|
2021
Q2 | $259K | Buy |
1,020
+497
| +95% | +$126K | ﹤0.01% | 4359 |
|
|
2021
Q1 | $93K | Sell |
523
-1,065
| -67% | -$189K | ﹤0.01% | 4664 |
|
|
2020
Q4 | $251K | Buy |
1,588
+559
| +54% | +$88.4K | ﹤0.01% | 4077 |
|
|
2020
Q3 | $226K | Sell |
1,029
-2,545
| -71% | -$559K | ﹤0.01% | 3683 |
|
|
2020
Q2 | $830K | Buy |
3,574
+3,512
| +5,665% | +$816K | ﹤0.01% | 3099 |
|
|
2020
Q1 | $11K | Sell |
62
-1
| -2% | -$177 | ﹤0.01% | 4443 |
|
|
2019
Q4 | $14K | Buy |
+63
| New | +$14K | ﹤0.01% | 4464 |
|